LTF and cancer: As already mentioned, the base of Lf anti-cancer specificity could be ascribed to the electrostatic binding, through its cationic N-terminal region, to acidic molecules highly expressed on the surface of cancer cells, including proteoglycans, GAGs and sialic acids [260,261,262].